Financials
Value Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses —————— — Research & development —————— — Operating income 1.02 B1.22 B1.1 B1.21 B1.22 B1.47 B 5 B Non-Operating Income, Total 168 M187 M265 M191 M59 M238 M 753 M Interest expense, net of interest capitalized 729 M734 M792 M770 M732 M803 M 3.1 B Non-Operating Income, excl. Interest Expenses -620 M-617 M-611 M-676 M-604 M-681 M -2.57 B Unusual income/expense 59 M70 M84 M97 M-69 M116 M 228 M Pretax income 459 M673 M569 M630 M551 M905 M 2.65 B Equity in earnings —————— — Taxes -215 M39 M20 M-220 M-119 M20 M -299 M Non-controlling/minority interest —————— — After tax other income/expense —————— — Net income before discontinued operations 674 M634 M549 M850 M670 M885 M 2.95 B Discontinued operations —————— — Net income 674 M634 M549 M850 M670 M885 M 2.95 B Dilution adjustment 000000 0 Preferred dividends 27 M27 M28 M27 M28 M27 M 110 M Diluted net income available to common stockholders 647 M607 M521 M823 M642 M858 M 2.84 B Basic earnings per share (Basic EPS) 0.310.280.240.370.290.39 1.29 Diluted earnings per share (Diluted EPS) 0.30.280.240.370.290.39 1.29 Average basic shares outstanding 2.14 B2.19 B2.2 B2.2 B2.2 B2.2 B — Diluted shares outstanding 2.15 B2.2 B2.2 B2.28 B2.2 B2.28 B — EBITDA —————— — EBIT 826 M1.02 B814 M1.03 B1.08 B1.29 B 4.22 B Cost of revenue 97 M100 M141 M89 M72 M89 M 391 M Other cost of goods sold —————— — Depreciation & amortization (cash flow) —————— —